A Pilot Study of Exendin-4 in Alzheimer s Disease
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 19 Nov 2016 Status changed from recruiting to completed.
- 03 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.
- 22 Aug 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2018 as reported by ClinicalTrials.gov.